Assembly Biosciences (ASMB) Competitors $15.04 +0.32 (+2.17%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ASMB vs. SBBP, NKTR, CPIX, LXRX, GILD, LLY, JNJ, ABBV, MRK, and PFEShould you be buying Assembly Biosciences stock or one of its competitors? The main competitors of Assembly Biosciences include Strongbridge Biopharma (SBBP), Nektar Therapeutics (NKTR), Cumberland Pharmaceuticals (CPIX), Lexicon Pharmaceuticals (LXRX), Gilead Sciences (GILD), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Co., Inc. (MRK), and Pfizer (PFE). These companies are all part of the "medical" sector. Assembly Biosciences vs. Strongbridge Biopharma Nektar Therapeutics Cumberland Pharmaceuticals Lexicon Pharmaceuticals Gilead Sciences Eli Lilly and Company Johnson & Johnson AbbVie Merck & Co., Inc. Pfizer Assembly Biosciences (NASDAQ:ASMB) and Strongbridge Biopharma (NASDAQ:SBBP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation, community ranking and media sentiment. Is ASMB or SBBP more profitable? Strongbridge Biopharma has a net margin of -115.67% compared to Assembly Biosciences' net margin of -144.05%. Strongbridge Biopharma's return on equity of -66.82% beat Assembly Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Assembly Biosciences-144.05% -121.46% -34.56% Strongbridge Biopharma -115.67%-66.82%-36.21% Does the media refer more to ASMB or SBBP? In the previous week, Assembly Biosciences had 3 more articles in the media than Strongbridge Biopharma. MarketBeat recorded 3 mentions for Assembly Biosciences and 0 mentions for Strongbridge Biopharma. Assembly Biosciences' average media sentiment score of 0.33 beat Strongbridge Biopharma's score of 0.00 indicating that Assembly Biosciences is being referred to more favorably in the media. Company Overall Sentiment Assembly Biosciences Neutral Strongbridge Biopharma Neutral Which has higher valuation & earnings, ASMB or SBBP? Strongbridge Biopharma has higher revenue and earnings than Assembly Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAssembly Biosciences$7.16M13.36-$61.23MN/AN/AStrongbridge Biopharma$30.73M4.41-$45.08M-$0.78-2.56 Which has more risk and volatility, ASMB or SBBP? Assembly Biosciences has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Strongbridge Biopharma has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500. Does the MarketBeat Community favor ASMB or SBBP? Strongbridge Biopharma received 68 more outperform votes than Assembly Biosciences when rated by MarketBeat users. However, 58.98% of users gave Assembly Biosciences an outperform vote while only 49.44% of users gave Strongbridge Biopharma an outperform vote. CompanyUnderperformOutperformAssembly BiosciencesOutperform Votes24358.98% Underperform Votes16941.02% Strongbridge BiopharmaOutperform Votes31149.44% Underperform Votes31850.56% Do institutionals and insiders believe in ASMB or SBBP? 19.9% of Assembly Biosciences shares are held by institutional investors. Comparatively, 52.0% of Strongbridge Biopharma shares are held by institutional investors. 5.1% of Assembly Biosciences shares are held by insiders. Comparatively, 5.1% of Strongbridge Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer ASMB or SBBP? Assembly Biosciences presently has a consensus price target of $35.00, suggesting a potential upside of 132.71%. Given Assembly Biosciences' stronger consensus rating and higher possible upside, research analysts plainly believe Assembly Biosciences is more favorable than Strongbridge Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Assembly Biosciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Strongbridge Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAssembly Biosciences beats Strongbridge Biopharma on 8 of the 15 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get Assembly Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ASMB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASMB vs. The Competition Export to ExcelMetricAssembly BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$95.65M$7.00B$5.38B$8.84BDividend YieldN/A8.11%5.14%4.09%P/E RatioN/A11.01105.9717.81Price / Sales13.36388.961,247.00162.50Price / CashN/A52.5940.3436.29Price / Book3.6810.377.086.50Net Income-$61.23M$153.60M$119.65M$226.10M7 Day Performance-6.82%4.53%2.15%3.98%1 Month Performance-10.42%-7.75%-3.13%3.78%1 Year Performance93.62%33.34%33.79%29.31% Assembly Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASMBAssembly Biosciences4.1588 of 5 stars$15.04+2.2%$35.00+132.7%+93.6%$95.65M$7.16M0.00100SBBPStrongbridge BiopharmaN/A$2.00flatN/A+0.0%$135.66M$30.73M-2.5672Gap DownNKTRNektar Therapeutics4.1335 of 5 stars$1.01+1.0%$3.50+246.5%+112.6%$186.31M$90.12M-1.20220CPIXCumberland Pharmaceuticals0.4591 of 5 stars$1.08-0.9%N/A-38.7%$15.16M$39.55M-1.4080LXRXLexicon Pharmaceuticals1.9776 of 5 stars$0.78-3.7%$6.00+669.1%-21.5%$192.09M$1.20M-1.04285Analyst ForecastGap DownGILDGilead Sciences4.6038 of 5 stars$89.84+1.4%$95.41+6.2%+19.1%$111.86B$28.30B998.2218,000Analyst ForecastAnalyst RevisionNews CoveragePositive NewsLLYEli Lilly and Company4.9919 of 5 stars$748.91-0.6%$1,007.94+34.6%+25.7%$710.96B$34.12B80.9643,000Analyst RevisionJNJJohnson & Johnson4.9567 of 5 stars$155.79+1.8%$175.94+12.9%+2.9%$375.08B$85.16B22.55131,900Positive NewsABBVAbbVie4.9685 of 5 stars$172.18+2.6%$203.50+18.2%+27.9%$304.27B$54.32B59.7850,000Analyst ForecastAnalyst RevisionPositive NewsMRKMerck & Co., Inc.4.9978 of 5 stars$100.41+3.0%$130.86+30.3%-2.5%$252.61B$63.17B21.0572,000Dividend IncreasePositive NewsPFEPfizer5 of 5 stars$25.06+0.5%$32.92+31.4%-15.5%$142.03B$58.50B33.8788,000Analyst DowngradeOptions VolumeAnalyst Revision Related Companies and Tools Related Companies Strongbridge Biopharma Alternatives Nektar Therapeutics Alternatives Cumberland Pharmaceuticals Alternatives Lexicon Pharmaceuticals Alternatives Gilead Sciences Alternatives Eli Lilly and Company Alternatives Johnson & Johnson Alternatives AbbVie Alternatives Merck & Co., Inc. Alternatives Pfizer Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ASMB) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Assembly Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Assembly Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
